Koseoğlu Sabri, Derin Serhan, Yilmaz Mustafa, Kutlu Gulnihal, Sahan Murat
Department of Otolaryngology, Mugla Sitki Kocman University, Mugla, Turkey.
Department of Neurology, Mugla Sitki Kocman University, Mugla, Turkey.
Int Forum Allergy Rhinol. 2017 Jun;7(6):557-560. doi: 10.1002/alr.21923. Epub 2017 Mar 8.
Olfactory function deteriorates in patients with severe obstructive sleep apnea syndrome (OSAS). The effect of positive airway pressure (PAP) therapy on olfactory function has not been investigated before. In this study, we aimed to investigate the role of PAP therapy on olfactory impairment in patients with OSAS.
Thirty patients who had OSAS and planned for PAP therapy were included in the study. All participants underwent a detailed otorhinolaryngological examination and polysomnography. The "Sniffin' Sticks" test was used for the analysis of olfactory function. The participants underwent the smell test before the PAP therapy, and about 3 months after the therapy. Pretreatment and posttreatment results were compared.
The pretreatment and the posttreatment apnea-hypopnea index (AHI) were 57.6 ± 29.8/hour and 9.5 ± 7.9/hour, respectively. Odor threshold (OT), odor discrimination (OD), odor identification (OI), and threshold-discrimination-identification (TDI) scores significantly increased after PAP therapy (p = 0.001, p = 0.002, p = 0.001, and p = 0.001, respectively). The pretreatment and posttreatment total TDI scores were 28.48 ± 4.71 and 32.50 ± 3.88, respectively (p = 0.001).
This study demonstrates olfactory dysfunction in patients with OSAS. We achieved a significant improvement in olfactory function of patients with OSAS after PAP therapy. Further studies are needed to illuminate the pathogenesis of olfactory dysfunction in OSAS, and the role of PAP therapy on olfactory improvement.
重度阻塞性睡眠呼吸暂停综合征(OSAS)患者的嗅觉功能会恶化。此前尚未研究过气道正压通气(PAP)治疗对嗅觉功能的影响。在本研究中,我们旨在探讨PAP治疗对OSAS患者嗅觉障碍的作用。
本研究纳入了30例计划接受PAP治疗的OSAS患者。所有参与者均接受了详细的耳鼻咽喉科检查和多导睡眠监测。采用“嗅觉棒”测试分析嗅觉功能。参与者在PAP治疗前及治疗后约3个月接受嗅觉测试。比较治疗前后的结果。
治疗前和治疗后的呼吸暂停低通气指数(AHI)分别为57.6±29.8次/小时和9.5±7.9次/小时。PAP治疗后,气味阈值(OT)、气味辨别(OD)、气味识别(OI)和阈值-辨别-识别(TDI)评分均显著提高(分别为p = 0.001、p = 0.002、p = 0.001和p = 0.001)。治疗前和治疗后的总TDI评分分别为28.48±4.71和32.50±3.88(p = 0.001)。
本研究证实了OSAS患者存在嗅觉功能障碍。PAP治疗后,OSAS患者的嗅觉功能有显著改善。需要进一步研究以阐明OSAS患者嗅觉功能障碍的发病机制,以及PAP治疗对嗅觉改善的作用。